GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

With nearly half of Americans saying weight loss is a goal for them, it’s no wonder that interest in GLP-1 medications has been on the rise. GLP-1 (short for glucagon-like peptide-1) medications ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

The company has been a big beneficiary of GLP-1 drugs that have seen soaring demand as they have been shown to greatly help with multiple health issues, including weight control. The stock has ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative. The stock is reasonably valued given the growth opportunities in front ...